Skip to main content

Main navigation

  • Home
  • About
    • About Us
    • Our Partners
    • Our People
  • Projects
    • Adverse Events of Special Interest in NZ Primary Care
    • Global COVID Vaccine Safety (GCoVS)
    • Genomics of COVID-19 Vaccine-Induced Adverse Events
    • SAFE [NZ background rates for AESI 2008–2019]
  • Resources
    • Blogs
    • Data Dashboard
    • Useful Links
    • News
    • Publications
    • Videos and Webinars
  • Contact
Global Vaccine Data Network Logo
Collaborating on vaccine safety and effectiveness studies using health data from around the world.
  1. Home
  2. News

GVDN Mobile Menu

  • Home
  • About
    • About Us
    • Our Partners
    • Our People
  • Projects
    • Adverse Events of Special Interest in NZ Primary Care
    • Global COVID Vaccine Safety (GCoVS)
    • Genomics of COVID-19 Vaccine-Induced Adverse Events
    • SAFE [NZ background rates for AESI 2008–2019]
  • Resources
    • Blogs
    • Data Dashboard
    • Useful Links
    • News
    • Publications
    • Videos and Webinars
  • Contact
News Banner

News

Banner
20 April 2022
GVDN partners in Finland and Denmark review post-mRNA COVID vaccination myocarditis and pericarditis in 23 million Nordic residents
Banner
13 April 2022
Pandemic propels global effort to study rare vaccine side effects
Banner
27 March 2022
Pregnancy outcomes following COVID-19 vaccination in Ontario, Norway, and Sweden
  • Home
  • Contact
  • Facebook
  • Waipapa Taumata Rau, University of Auckland
  • Accessibility
  • Copyright
  • Privacy
  • Disclaimer